Examine evaluates polygenic threat rating for prostate most cancers threat prediction | VUMC Reporter
Analysis by Mingjian Shi, PhD, left, Jonathan Mosley, MD, PhD, Kerry Schaffer, MD, MSCI, and colleagues discovered that polygenic threat rating doesn’t enhance prediction of aggressive prostate most cancers. (picture by Susan Urmy) by Leigh MacMillan A prostate most cancers polygenic threat rating (PRS) has restricted utility for enhancing prostate most cancers screening, in response […]
Continue Reading
/cloudfront-us-east-1.images.arcpublishing.com/dmn/QCTM6DODWJDMLOUVGUON2MM7H4.jpg "Caris Life Sciences nears billion in whole funding for precision most cancers analysis")
